Oral Taxane

DRUG3 trials

Sponsors

Bristol-Myers Squibb

Conditions

CancerNon-small Cell Lung Cancer

Phase 1

Oral Taxane in Combination With Pemetrexed (Alimta) in Patients With Recurrent Non-Small Cell Lung Cancer

CompletedNCT00103831

Bristol-Myers SquibbNon-small Cell Lung Cancer

Updated: 2010-03-02

A Phase I Study of a Single Dose of Radio-labeled BMS-275183 in Patients With Advanced Cancer

TerminatedNCT00326131

Bristol-Myers SquibbCancer

Start: 2006-04-30Target: 6Updated: 2010-03-02

A Phase I Study of BMS-275183 (Oral Taxane) Given on a Daily Schedule in Combination With Esomeprazole (Nexium) in Patients With Advanced Cancer

TerminatedNCT00332748

Bristol-Myers SquibbCancer

Start: 2006-12-31Target: 36Updated: 2010-03-02